Labshake search
Citations for R&D Systems :
551 - 600 of 4242 citations for 9 10 Dihydro 4H benzo 4 5 cyclohepta 1 2 b thiophen 4 one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... 0.5mM EDTA and 0.05% Sodium azide) for 20 minutes at 4°C following which cells were stained in suspension for anti-mouse TREM2 biotinylated (R&D systems, BAF1729) for 30 minutes at 4°C ...
-
bioRxiv - Synthetic Biology 2021Quote: ... Macrophage cell lysates were collected at 4 h post-infection and subjected to Western blot for GNLY (R&D Systems Cat# AF3138-SP), CCL20 (R&D Systems Cat# AF360-SP) ...
-
bioRxiv - Genomics 2023Quote: ... was applied for 30 minutes at room temperature followed by primary antibody staining overnight at 4°C using anti-CD206 (R&D systems, AF2534), anti-CD11b (Cell Sciences ...
-
bioRxiv - Biophysics 2023Quote: ... 100 μL of isolated EV sample was mixed with 4 μL of Alexa488 anti-human TNFRSF10B antibody (FAB6311G, R&D Systems, Minneapolis, MN) and 2 μL of PE anti-human CD63 antibody (561925 ...
-
bioRxiv - Immunology 2023Quote: ... cells were stained for 40 min at 4°C with fluorophore-conjugated antibodies PE-anti-Glut1 (clone 202915 R&D Systems, Minnesota, USA) and in parallel ...
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Neuroscience 2019Quote: ... Primary antibodies (Claudin-5, Abcam Ab131259, 1:1000; Collagen IV, Abcam Ab6586, 1:500; Hemoglobin, R&D Systems G-134-C ...
-
bioRxiv - Systems Biology 2023Quote: ... and stained for total and relevant phosphoproteins with the following antibodies in one of the three tubes: Tube 1: mouse monoclonal anti-human RPS6 (Clone 522731, catalog # MAB5436, R&D Systems) and rabbit polyclonal anti-human Phospho-RPS6 (Catalog # AF3918 ...
-
bioRxiv - Bioengineering 2020Quote: ... medium was switched to STEMdiff APEL medium supplemented with 200 ng/μl FGF-9 (R&D Systems) and 1 μg/ml heparin (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2023Quote: ... lactoferrin and MMP-9 were detected in undiluted supernatant using ELISA kits (abcam and R&D systems).
-
bioRxiv - Bioengineering 2019Quote: ... Cells were maintained in proliferating state using 10 ng/ml fibroblast growth factor 2 (FGF2; R&D Systems) and passaged twice before usage in the experiments ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL recombinant human IGF-1 (R&D Systems, USA), and 200 ng/mL L-ascorbic acid (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2022Quote: ... anti-integrin β1 (1:10, AF 2325; R&D Systems; EM), anti-integrin α1 goat (1:500 ...
-
bioRxiv - Biophysics 2023Quote: ... either with 10 μg/mL human ICAM-1 (R&D Systems), 1 μg/mL CCL21 (Miltenyi biotech ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL−1 Activin A (338-AC, R&D Systems) was added for three days ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 ng/mL recombinant human insulin-like growth factor 1 (IGF-1) (R&D Systems, USA), and 10 μM SB431542 (Tocris ...
-
bioRxiv - Cell Biology 2022Quote: ... DPP4 (IF/FACS 1:100, #HBB3/775/42, DSHB; EM 1:10, #AF1180, R&D Systems), E-Cadherin (IF 1:200 ...
-
bioRxiv - Immunology 2020Quote: ... or a combination of 2 µg/ml ICAM-1 (R&D Systems), 1 µg/ml NKp30 (R&D systems ...
-
Apical expansion of calvarial osteoblasts and suture patency is dependent on graded fibronectin cuesbioRxiv - Developmental Biology 2023Quote: ... Goat anti-Runx 2 (1:100; R&D Systems AF2006-SP; RRID:AB_2184528) and mouse anti-GM130 (1:100 ...
-
bioRxiv - Neuroscience 2024Quote: ... Oligodendrocyte Transcription Factor 2 (Olig2, Cat# AF2418, R&D system, 1:500), S100 Calcium Binding Protein A10 (S100A10 ...
-
bioRxiv - Immunology 2021Quote: ... 115-006-068), 250ng/ml mouse recombinant MEGACD40L (Enzo, ALX-522-120) and 20ng/ml Recombinant mouse IL-4 (R&D system, 404-ML). Cells were collected at specific time points for analysis ...
-
bioRxiv - Cancer Biology 2020Quote: ... 1mL of Chromatin was incubated 12-16 hours at 4°C with 10μg of antibody (α-RNA Pol2 [sera from Gardini lab], α-Twist [Abcam ab50887], α-Snail [R&D Systems AF3639] ...
-
bioRxiv - Immunology 2020Quote: Macrophages were centrifuged for 7 minutes at 1200 rpm and then stained for 40 minutes at 4°C with fluor ophore-conjugated antibodies PE-anti-Glut1 (clone 202915 R&D Systems, Minnesota, USA) and in parallel ...
-
bioRxiv - Immunology 2020Quote: ... cells were also incubated overnight at 4°C with a sheep anti-Lamp1 Alexa Fluor 488-conjugated (lysosomal marker) antibody (R&D systems, Cat# IC7985G) at 1:10 or a rabbit anti-CD71 (transferrin receptor ...
-
bioRxiv - Immunology 2020Quote: ... and IL-10 were measured in the cell-free supernatants of control and treated MoDCs cultures (4×105 cells/ml) by ELISA assays (R&D Systems, Minneapolis, USA). The levels of cytokines produced by CD4+ T lymphocytes in co-cultures with MoDCs were evaluated in the cell-free supernatants of co-cultures ...
-
bioRxiv - Cell Biology 2022Quote: ... MC3T3-E1 Subclone 4 preosteoblasts (ATCC CRL-2593) grown in monolayer were treated with vehicle or CXCL12 (20 μg/ml, R&D Systems, 460-SD) for 4 hours ...
-
bioRxiv - Immunology 2022Quote: ... were cultured in OptiMEM reduced serum media buffered with sodium bicarbonate and supplemented with 4% (v/v) fetal bovine serum (FBS, R&D Systems, Minneapolis, MN). The cells were grown at 37 °C in a 5% CO2 humidified atmosphere ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant cathepsin B and cathepsin L were purchased from R&D Systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was purchased from R&D systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was from R&D Systems (UK) and used at a final concentration of 0.5 ng/ml ...
-
bioRxiv - Molecular Biology 2023Quote: ... 10% FBS and Penicillin-Streptomycin) with or without 5 μg/ml recombinant human MANF protein (R&D systems, 3748-MN). For EdU cell proliferation assay and Ca2+ measurement ...
-
bioRxiv - Cell Biology 2019Quote: ... C2C12 and cardiac fibroblasts were serum starved for 24 h before adding medium containing 5 ng/ml recombinant TGFβ1 for 2 days (R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2020Quote: ... IL-5 (5 ng/ml, R&D Systems), TGF-β (3 ng/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... after which the cells were exposed for 3 days to 200 ng/ml FGF-9 (R&D systems) and 1μg/mL heparin (Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... half-medium exchange was performed and 10 IU/mL IL-2 (R&D Systems; Cat no 202-IL-500) added ...
-
bioRxiv - Immunology 2022Quote: ... T cells then were washed and further incubated with recombinant human IL-2 (10 ng/ml; R&D systems) for up to 2 weeks at 37°C incubator with medium change every 3 days ...
-
bioRxiv - Cell Biology 2023Quote: ... and the medium was supplemented with 10 ng/ml rhFGF-2 and 20 ng/ml VEGF (R&D Systems) for EC expansion ...
-
bioRxiv - Cell Biology 2023Quote: ... starved for 2 hours and treated with 10 ng/ml rat recombinant EGF (R&D Systems, Minneapolis, MN, USA) for 5 min ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 5 ng mL-1 of IL-7 and IL-15 (R&D Systems). Regulatory T cells were activated at 1 x 106 cells mL-1 for 2 days in complete XVivo15 supplemented with magnetic Treg Xpander CTS Dynabeads (ThermoFisher ...
-
bioRxiv - Immunology 2023Quote: ... 1 ng/ml IL-12 and 5 ng/ml IL-15 (R&D Systems). Re-stimulation with irradiated (100 Gy) ...
-
bioRxiv - Immunology 2019Quote: ... and homogenates were diluted to 2 mg/mL protein in PBS and were subsequently diluted 1:2 in Reagent Diluent (R&D Systems). CXCL10 protein was quantified using the Mouse CXCL10 Duoset ELISA kit (R&D Systems ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 24 and 48 hours intervals from 3 BALB/C mice carrying RCC tumours receiving 1×107 PODS-IL-2 treatment following the final dose and tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Immunology 2022Quote: ... anti-IL-10 (50 μg ml−1, clone JES052A5, R&D Systems) and stimulated with polyclonal anti-CD3 (1 μg ml−1 ...
-
bioRxiv - Bioengineering 2020Quote: ... 10 ng mL−1 IL-1α (R&D Systems # 400-ML-005), 10 ng mL−1 IL-13 (R&D Systems # 413-ML-005) ...
-
bioRxiv - Bioengineering 2020Quote: ... 10 ng mL−1 IL-13 (R&D Systems # 413-ML-005), and 10 ng mL−1 IFN-γ (R&D Systems # 485-MI-100 ...
-
bioRxiv - Immunology 2019Quote: ... or 1 μM IL-8 (R&D Systems # 208-IL-10/CF) was loaded onto the devices ...
-
bioRxiv - Neuroscience 2019Quote: ... The antibodies used were: VE-Cadherin (R&D systems AF1002, 1/10) and ZO1 (Invitrogen 61-7300 ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng/mL Recombinant Mouse CSF-1 (R&D Systems, 416-ML), and 1x Antibiotic-Antimycotic (Gibco ...
-
bioRxiv - Cell Biology 2020Quote: ... FFPE pancreas sections were incubated overnight at +4°C with primary antibody monoclonal mouse anti-human ACE2 (cat. MAB933, R&D System, Minneapolis, MS, USA) diluted 1:33 in PBS 1X supplemented with 3% BSA and with polyclonal rabbit anti-CD31 (cat ...